OPGx-RDH12

N/A

Report date: 2024/10/28 09:28:25

Base Information

Drug NameOPGx-RDH12
Drug Alias NameOPGx-RDH12
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRetinol dehydrogenase 12 gene transference
TargetsRetinol dehydrogenase 12
Therapy Area/IndicationsRetinal Dysplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOpus Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlobal RDH12 AllianceOpus Genetics Inc
Inactive CompaniesN/A
Active IndicationsRetinal Dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A